There are 2137 resources available
972TiP - Phase II study of intratumoral MK-1454 plus pembrolizumab compared with pembrolizumab monotherapy as first-line treatment for metastatic or unresectable, recurrent head and neck squamous cell carcinoma
Presenter: Kevin Harrington
Session: E-Poster Display
Resources:
Abstract
973TiP - LEAP-010: Phase III study of first-line pembrolizumab with or without lenvatinib in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Presenter: Lillian Siu
Session: E-Poster Display
Resources:
Abstract
974TiP - Exploratory phase Ib/IIa study of intratumorally administered tigilanol tiglate to assess safety, tolerability and tumour response in patients with head and neck squamous cell carcinoma
Presenter: Richard Gallagher
Session: E-Poster Display
Resources:
Abstract
975TiP - Phase Ib trial of ABBV-368 + tilsotolimod in combination with nab-paclitaxel and/or budigalimab (ABBV-181) in patients with recurrent/metastatic head and neck squamous cell carcinoma
Presenter: Xiuning Le
Session: E-Poster Display
Resources:
Abstract
976TiP - SPEARHEAD-2 trial design: A phase II pilot trial of ADP-A2M4 in combination with pembrolizumab in patients with recurrent or metastatic head and neck cancer
Presenter: Ezra Cohen
Session: E-Poster Display
Resources:
Abstract
977TiP - Role of microbiome as a biomarker in locoregionally-advanced oropharyngeal squamous cell carcinoma 2 (ROMA LA-OPSCC2)
Presenter: Geoffrey Watson
Session: E-Poster Display
Resources:
Abstract
978TiP - Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase I/II trial
Presenter: Pierluigi Bonomo
Session: E-Poster Display
Resources:
Abstract
979TiP - POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients with performance status 2 with recurrent or metastatic squamous cell carcinoma of the head and neck
Presenter: Sharon Forsyth
Session: E-Poster Display
Resources:
Abstract
980TiP - VOICE- head and neck cancer patient journey’s health literacy needs and experience: Patient, caregivers and healthcare professionals’ perspectives
Presenter: Claudia Vieira
Session: E-Poster Display
Resources:
Abstract
982P - Comparison of donafenib and sorafenib as advanced hepatocellular carcinoma first-line treatments: Subgroup analysis of an open-label, randomized, parallel-controlled, multicentre phase II/III trial
Presenter: Shukui Qin
Session: E-Poster Display
Resources:
Abstract